{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:17:27Z","timestamp":1791235047519,"version":"4.1.0"},"reference-count":84,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1097\/wco.0b013e32832ffbe3","type":"journal-article","created":{"date-parts":[[2009,9,15]],"date-time":"2009-09-15T07:15:29Z","timestamp":1252998929000},"page":"486-492","source":"Crossref","is-referenced-by-count":61,"title":["Recent advances in motor neuron disease"],"prefix":"10.1097","volume":"22","author":[{"given":"Philip","family":"Van Damme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Robberecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210206","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35097565","article-title":"From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS","volume":"2","author":"Cleveland","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"R2-7-20210206","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"key":"R3-7-20210206","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrn1971","article-title":"Molecular biology of amyotrophic lateral sclerosis: insights from genetics","volume":"7","author":"Pasinelli","year":"2006","journal-title":"Nat Rev Neurosci"},{"issue":"Suppl 1","key":"R4-7-20210206","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ana.21543","article-title":"Current hypotheses for the underlying biology of amyotrophic lateral sclerosis","volume":"65","author":"Rothstein","year":"2009","journal-title":"Ann Neurol"},{"key":"R5-7-20210206","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS\/Riluzole Study Group","volume":"330","author":"Bensimon","year":"1994","journal-title":"N Engl J Med"},{"key":"R6-7-20210206","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(96)91680-3","article-title":"Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis\/Riluzole Study Group II","volume":"347","author":"Lacomblez","year":"1996","journal-title":"Lancet"},{"key":"R7-7-20210206","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S1474-4422(05)70223-4","article-title":"Frontotemporal dementia","volume":"4","author":"Neary","year":"2005","journal-title":"Lancet Neurol"},{"key":"R8-7-20210206","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","article-title":"Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria","volume":"51","author":"Neary","year":"1998","journal-title":"Neurology"},{"key":"R9-7-20210206","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.jnen.0000174335.27708.0a","article-title":"Ubiquitin immunohistochemistry suggests classic motor neuron disease, motor neuron disease with dementia, and frontotemporal dementia of the motor neuron disease type represent a clinicopathologic spectrum","volume":"64","author":"Mackenzie","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"R10-7-20210206","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000077167","article-title":"Characterization of amyotrophic lateral sclerosis and frontotemporal dementia","volume":"17","author":"Lomen-Hoerth","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"key":"R11-7-20210206","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/brain\/awh170","article-title":"Word retrieval in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study","volume":"127","author":"Abrahams","year":"2004","journal-title":"Brain"},{"key":"R12-7-20210206","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00401-004-0900-9","article-title":"Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration","volume":"108","author":"Lipton","year":"2004","journal-title":"Acta Neuropathol (Berl)"},{"key":"R13-7-20210206","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"R14-7-20210206","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","article-title":"TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"351","author":"Arai","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"R15-7-20210206","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/WCO.0b013e3283168d1d","article-title":"The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia","volume":"21","author":"Mackenzie","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"R16-7-20210206","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1212\/01.wnl.0000339487.84908.00","article-title":"A case of ALS-FTD in a large FALS pedigree with a K17I ANG mutation","volume":"72","author":"van Es","year":"2009","journal-title":"Neurology"},{"key":"R17-7-20210206","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21612","article-title":"TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration","volume":"65","author":"Benajiba","year":"2009","journal-title":"Ann Neurol"},{"key":"R18-7-20210206","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.nbd.2008.11.008","article-title":"Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide","volume":"33","author":"Benussi","year":"2009","journal-title":"Neurobiol Dis"},{"key":"R19-7-20210206","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/brain\/awl030","article-title":"Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2\u201321.3","volume":"129","author":"Vance","year":"2006","journal-title":"Brain"},{"key":"R20-7-20210206","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1001\/jama.284.13.1664","article-title":"Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22","volume":"284","author":"Hosler","year":"2000","journal-title":"JAMA"},{"key":"R21-7-20210206","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/ng0595-61","article-title":"Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase","volume":"10","author":"Andersen","year":"1995","journal-title":"Nat Genet"},{"key":"R22-7-20210206","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1212\/WNL.47.5.1336","article-title":"D90A heterozygosity in the SOD1 gene is associated with familial and apparently sporadic amyotrophic lateral sclerosis","volume":"47","author":"Robberecht","year":"1996","journal-title":"Neurology"},{"key":"R23-7-20210206","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1086\/425287","article-title":"A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis","volume":"75","author":"Nishimura","year":"2004","journal-title":"Am J Hum Genet"},{"key":"R24-7-20210206","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ng1742","article-title":"ANG mutations segregate with familial and \u2018sporadic\u2019 amyotrophic lateral sclerosis","volume":"38","author":"Greenway","year":"2006","journal-title":"Nat Genet"},{"key":"R25-7-20210206","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ng1001-160","article-title":"The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis","volume":"29","author":"Yang","year":"2001","journal-title":"Nat Genet"},{"key":"R26-7-20210206","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00401-007-0206-9","article-title":"TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation","volume":"113","author":"Tan","year":"2007","journal-title":"Acta Neuropathol"},{"key":"R27-7-20210206","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.21147","article-title":"Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations","volume":"61","author":"Mackenzie","year":"2007","journal-title":"Ann Neurol"},{"key":"R28-7-20210206","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neulet.2007.03.066","article-title":"Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS","volume":"420","author":"Robertson","year":"2007","journal-title":"Neurosci Lett"},{"key":"R29-7-20210206","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/nen.0b013e3181567f02","article-title":"A reassessment of the neuropathology of frontotemporal dementia linked to chromosome 3","volume":"66","author":"Holm","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"R30-7-20210206","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/NEN.0b013e3181919cb5","article-title":"Nuclear TAR DNA binding protein 43 expression in spinal cord neurons correlates with the clinical course in amyotrophic lateral sclerosis","volume":"68","author":"Sumi","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"key":"R31-7-20210206","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neulet.2009.04.031","article-title":"Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS","volume":"458","author":"Shan","year":"2009","journal-title":"Neurosci Lett"},{"key":"R32-7-20210206","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ng.132","article-title":"TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis","volume":"40","author":"Kabashi","year":"2008","journal-title":"Nat Genet"},{"key":"R33-7-20210206","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/jmg.2008.062463","article-title":"Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis","volume":"46","author":"Daoud","year":"2009","journal-title":"J Med Genet"},{"key":"R34-7-20210206","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ana.21344","article-title":"TDP-43 A315T mutation in familial motor neuron disease","volume":"63","author":"Gitcho","year":"2008","journal-title":"Ann Neurol"},{"key":"R35-7-20210206","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/jnnp.2008.157677","article-title":"TDP-43 M311V mutation in familial amyotrophic lateral sclerosis","volume":"80","author":"Lemmens","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R36-7-20210206","doi-asserted-by":"crossref","first-page":"e1000193","DOI":"10.1371\/journal.pgen.1000193","article-title":"Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis","volume":"4","author":"Rutherford","year":"2008","journal-title":"PLoS Genet"},{"key":"R37-7-20210206","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"key":"R38-7-20210206","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1474-4422(08)70071-1","article-title":"TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis","volume":"7","author":"Van Deerlin","year":"2008","journal-title":"Lancet Neurol"},{"key":"R39-7-20210206","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ana.21392","article-title":"TDP-43 mutation in familial amyotrophic lateral sclerosis","volume":"63","author":"Yokoseki","year":"2008","journal-title":"Ann Neurol"},{"key":"R40-7-20210206","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.1166066","article-title":"Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis","volume":"323","author":"Kwiatkowski","year":"2009","journal-title":"Science"},{"key":"R41-7-20210206","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.1165942","article-title":"Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6","volume":"323","author":"Vance","year":"2009","journal-title":"Science"},{"key":"R42-7-20210206","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.cell.2009.03.006","article-title":"Rethinking ALS: the FUS about TDP-43","volume":"136","author":"Lagier-Tourenne","year":"2009","journal-title":"Cell"},{"key":"R43-7-20210206","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000114962","article-title":"Monozygous twins discordant for amyotrophic lateral sclerosis","volume":"17","author":"Jokelainen","year":"1978","journal-title":"Eur Neurol"},{"key":"R44-7-20210206","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1474-4422(07)70037-6","article-title":"Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data","volume":"6","author":"Schymick","year":"2007","journal-title":"Lancet Neurol"},{"key":"R45-7-20210206","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S1474-4422(07)70222-3","article-title":"ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study","volume":"6","author":"van Es","year":"2007","journal-title":"Lancet Neurol"},{"key":"R46-7-20210206","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/hmg\/ddm361","article-title":"A genome-wide association study of sporadic ALS in a homogenous Irish population","volume":"17","author":"Cronin","year":"2008","journal-title":"Hum Mol Genet"},{"key":"R47-7-20210206","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ng.2007.52","article-title":"Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis","volume":"40","author":"van Es","year":"2008","journal-title":"Nat Genet"},{"key":"R48-7-20210206","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/hmg\/ddn375","article-title":"Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration","volume":"18","author":"Simpson","year":"2009","journal-title":"Hum Mol Genet"},{"key":"R49-7-20210206","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1093\/hmg\/ddp059","article-title":"A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis","volume":"18","author":"Chio","year":"2009","journal-title":"Hum Mol Genet"},{"key":"R50-7-20210206","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1073\/pnas.0812937106","article-title":"Reduced expression of the kinesin-associated protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis","volume":"106","author":"Landers","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R51-7-20210206","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1126\/science.1123511","article-title":"Onset and progression in inherited ALS determined by motor neurons and microglia","volume":"312","author":"Boillee","year":"2006","journal-title":"Science"},{"key":"R52-7-20210206","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/nn1988","article-title":"Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease","volume":"10","author":"Lobsiger","year":"2007","journal-title":"Nat Neurosci"},{"key":"R53-7-20210206","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/nn.2210","article-title":"Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease","volume":"11","author":"Lepore","year":"2008","journal-title":"Nat Neurosci"},{"key":"R54-7-20210206","doi-asserted-by":"crossref","first-page":"10234","DOI":"10.1523\/JNEUROSCI.3494-08.2008","article-title":"Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase","volume":"28","author":"Gowing","year":"2008","journal-title":"J Neurosci"},{"key":"R55-7-20210206","doi-asserted-by":"crossref","first-page":"17913","DOI":"10.1073\/pnas.0804610105","article-title":"T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS","volume":"105","author":"Chiu","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"R56-7-20210206","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0807419105","article-title":"CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS","volume":"105","author":"Beers","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R57-7-20210206","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1126\/science.1158799","article-title":"Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons","volume":"321","author":"Dimos","year":"2008","journal-title":"Science"},{"key":"R58-7-20210206","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1172\/JCI25424","article-title":"Antisense oligonucleotide therapy for neurodegenerative disease","volume":"116","author":"Smith","year":"2006","journal-title":"J Clin Invest"},{"key":"R59-7-20210206","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nm1207","article-title":"Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS","volume":"11","author":"Raoul","year":"2005","journal-title":"Nat Med"},{"key":"R60-7-20210206","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature02544","article-title":"VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model","volume":"429","author":"Azzouz","year":"2004","journal-title":"Nature"},{"key":"R61-7-20210206","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/88842","article-title":"Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration","volume":"28","author":"Oosthuyse","year":"2001","journal-title":"Nat Genet"},{"key":"R62-7-20210206","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nn1360","article-title":"Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS","volume":"8","author":"Storkebaum","year":"2005","journal-title":"Nat Neurosci"},{"key":"R63-7-20210206","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000089620","article-title":"Excitotoxicity and amyotrophic lateral sclerosis","volume":"2","author":"Van Damme","year":"2005","journal-title":"Neurodegener Dis"},{"key":"R64-7-20210206","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1523\/JNEUROSCI.16-13-04069.1996","article-title":"Motor neurons are selectively vulnerable to AMPA\/kainate receptor-mediated injury in vitro","volume":"16","author":"Carriedo","year":"1996","journal-title":"J Neurosci"},{"key":"R65-7-20210206","doi-asserted-by":"crossref","first-page":"14825","DOI":"10.1073\/pnas.0705046104","article-title":"Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity","volume":"104","author":"Van Damme","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R66-7-20210206","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/hmg\/ddh246","article-title":"Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model","volume":"13","author":"Tateno","year":"2004","journal-title":"Hum Mol Genet"},{"key":"R67-7-20210206","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/01.jnen.0000171647.09589.07","article-title":"GluR2 deficiency accelerates motor neuron degeneration in a mouse model of amyotrophic lateral sclerosis","volume":"64","author":"Van Damme","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"R68-7-20210206","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature03180","article-title":"Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression","volume":"433","author":"Rothstein","year":"2005","journal-title":"Nature"},{"key":"R69-7-20210206","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1073\/pnas.0708022105","article-title":"Lithium delays progression of amyotrophic lateral sclerosis","volume":"105","author":"Fornai","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R70-7-20210206","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1474-4422(05)70326-4","article-title":"Effects of noninvasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial","volume":"5","author":"Bourke","year":"2006","journal-title":"Lancet Neurol"},{"key":"R71-7-20210206","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/14660820310011728","article-title":"Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction","volume":"4","author":"Mitsumoto","year":"2003","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"R72-7-20210206","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00415-004-0429-9","article-title":"Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis\/motor neurone disease: a record linkage study from the Scottish Motor Neurone Disease Register","volume":"251","author":"Forbes","year":"2004","journal-title":"J Neurol"},{"key":"R73-7-20210206","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/jnnp.74.9.1258","article-title":"Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996\u20132000","volume":"74","author":"Traynor","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R74-7-20210206","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/jnnp.2005.083402","article-title":"Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities","volume":"77","author":"Chio","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R75-7-20210206","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archneur.63.8.1139","article-title":"Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?","volume":"63","author":"Czaplinski","year":"2006","journal-title":"Arch Neurol"},{"key":"R76-7-20210206","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/archneur.1995.00540300031009","article-title":"Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis","volume":"52","author":"Louwerse","year":"1995","journal-title":"Arch Neurol"},{"key":"R77-7-20210206","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-0404.1997.tb00231.x","article-title":"A clinical trial of dextromethorphan in amyotrophic lateral sclerosis","volume":"96","author":"Gredal","year":"1997","journal-title":"Acta Neurol Scand"},{"key":"R78-7-20210206","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/146608201300079364","article-title":"A double-blind, placebo-controlled randomized clinical trial of alpha- tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group","volume":"2","author":"Desnuelle","year":"2001","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"R79-7-20210206","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/mus.20450","article-title":"Pulmonary predictors of survival in amyotrophic lateral sclerosis: use in clinical trial design","volume":"33","author":"Schmidt","year":"2006","journal-title":"Muscle Nerve"},{"key":"R80-7-20210206","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ana.10554","article-title":"A randomized sequential trial of creatine in amyotrophic lateral sclerosis","volume":"53","author":"Groeneveld","year":"2003","journal-title":"Ann Neurol"},{"key":"R81-7-20210206","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00702-004-0220-1","article-title":"High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study","volume":"112","author":"Graf","year":"2005","journal-title":"J Neural Transm"},{"key":"R82-7-20210206","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/01.wnl.0000191326.40772.62","article-title":"Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial","volume":"66","author":"Meininger","year":"2006","journal-title":"Neurology"},{"key":"R83-7-20210206","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ana.20903","article-title":"Trial of celecoxib in amyotrophic lateral sclerosis","volume":"60","author":"Cudkowicz","year":"2006","journal-title":"Ann Neurol"},{"key":"R84-7-20210206","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1212\/01.wnl.0000335970.78664.36","article-title":"Subcutaneous IGF-1 is not beneficial in 2-year ALS trial","volume":"71","author":"Sorenson","year":"2008","journal-title":"Neurology"}],"container-title":["Current Opinion in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WCO.0b013e32832ffbe3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T08:09:07Z","timestamp":1620979747000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00019052-200910000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/wco.0b013e32832ffbe3","relation":{},"ISSN":["1350-7540"],"issn-type":[{"value":"1350-7540","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}